Monsanto PT Raised to $150.00 at Morgan Stanley (MON)
Investment analysts at Morgan Stanley upped their target price on shares of Monsanto (NYSE:MON) to $150.00 in a note issued to investors on Monday, Analyst RN reports. Morgan Stanley’s target price indicates a potential upside of 28.92% from the stock’s previous close.
Several other analysts have also recently commented on the stock. Analysts at Susquehanna raised their price target on shares of Monsanto from $128.00 to $145.00 in a research note to investors on Monday. Separately, analysts at UBS AG raised their price target on shares of Monsanto from $110.00 to $118.00 in a research note to investors on Monday, November 11th. They now have a “buy” rating on the stock. Finally, analysts at Jefferson Research downgraded shares of Monsanto from a “hold” rating to a “sell” rating in a research note to investors on Tuesday, October 29th. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and twelve have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $119.53.
Monsanto (NYSE:MON) traded down 0.29% during mid-day trading on Monday, hitting $116.01. 747,652 shares of the company’s stock traded hands. Monsanto has a 52 week low of $94.00 and a 52 week high of $117.50. The stock’s 50-day moving average is $112. and its 200-day moving average is $104.8. The company has a market cap of $61.002 billion and a price-to-earnings ratio of 25.29.
The company also recently declared a quarterly dividend, which is scheduled for Friday, January 31st. Shareholders of record on Friday, January 10th will be given a dividend of 0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.48%. The ex-dividend date of this dividend is Wednesday, January 8th.
Monsanto Company (NYSE:MON), along with its subsidiaries, is a provider of agricultural products for farmers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.